In summary, we delineate a melatonin/YTHDF3/DAPK2 protective axis that safeguards against unloading‐induced bone deterioration via post‐transcriptional regulation of Dapk2, thereby unveiling new mechanistic perspectives and therapeutic opportunities for disuse osteoporosis. The gene discussed is DAPK2; the disease is osteoporosis.